Gene: STPG4
Official Full Name: sperm-tail PG-rich repeat containing 4provided by HGNC
Gene Summary: Predicted to enable chromatin binding activity and histone binding activity. Predicted to be involved in epigenetic programing of male pronucleus. Predicted to act upstream of or within pyrimidine-containing compound catabolic process. Predicted to be located in cytoplasm and nucleus. Predicted to be active in female pronucleus; germinal vesicle; and male pronucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13669 | STPG4 Knockout cell line (HCT 116) | Human | STPG4 | 1:2~1:4 | Negative | Online Inquiry |
STPG4 Gene Knockout Cell Lines are an innovative biological tool specifically designed for research applications involving the STPG4 gene, which has been implicated in various cellular processes, including metabolism and signal transduction. By using CRISPR-Cas9 technology, these cell lines have been engineered to facilitate the precise disruption of the STPG4 gene, allowing researchers to study its functions, interactions, and potential implications in human diseases.
The primary mechanism by which the STPG4 Gene Knockout Cell Lines operate involves the introduction of targeted double-strand breaks in the DNA, followed by the cell's DNA repair mechanisms leading to insertions or deletions that disrupt normal gene function. This knockout model provides a robust framework for exploring both the physiological role of STPG4 and its involvement in various pathologies, such as metabolic disorders and cancer.
From a scientific perspective, these cell lines hold significant importance in research settings, enabling insights into gene function and the identification of potential therapeutic targets. Additionally, they can serve as valuable platforms for drug testing and the evaluation of gene therapy approaches. Clinically, understanding the role of STPG4 could pave the way for novel treatment strategies, further highlighting their relevance.
Unlike alternative products on the market, our STPG4 Gene Knockout Cell Lines boast a higher efficiency of gene editing, minimal off-target effects, and enhanced stability, providing researchers with confidence in their experimental results. Moreover, they are extensively validated, ensuring reproducibility and reliability in experiments.
For researchers and clinicians alike, the value of STPG4 Gene Knockout Cell Lines lies not only in their capacity to facilitate cutting-edge discoveries but also in their role in advancing personalized medicine. Our company, with extensive experience in genetic engineering and cell biology, is committed to delivering high-quality biological products that empower scientific inquiry and innovation. We understand the needs of researchers in this fast-paced field, and we strive to deliver solutions that enhance the efficiency and effectiveness of your work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.